Please login to the form below
Ariad Pharma
This page shows the latest Ariad Pharma news and features for those working in and with pharma, biotech and healthcare.
Takeda rebels take aim at Shire acquisition
of bolt-on acquisitions and licensing deals, including the $5.2bn takeover of cancer company Ariad Pharma.
Latest news
-
Angelini to market Ariad’s Iclusig in Eastern Europe
Angelini to market Ariad’ s Iclusig in Eastern Europe. Comes after leukaemia drug passes EMA safety review. ... US pharma company Ariad Pharmaceuticals has licensed its cancer drug Iclusig to Italy-based firm Angelini Pharma to market in 23 Eastern
-
Pfizer faces NICE rejection for cancer drug Bosulif
In April 2013 an article in the journal Blood saw 20 physicians specialising in CML treatment call for price reductions for CML drugs, claiming that Bosulif, Ariad Pharma's Iclusig (ponatinib) ... So far this pressure has been focused on the US, however
-
Leukaemia drug prices "unsustainable" say cancer experts
The experts single out three new drugs for CML approved by the FDA last year - Pfizer's Bosulif (bosutinib), Ariad Pharma's Iclusig (ponatinib) and Teva's Synribo (omacetaxine) - which they
-
EU recommendations for Gilead, Ariad and Baxter drugs
Gilead Sciences, Ariad Pharma and Baxter have all received backing from the European Medicines Agency (EMA) to market new treatments. ... Iclusig approved to treat leukaemia. The CHMP also gave a positive opinion to Ariad Pharma for the use of Iclusig
More from news
Approximately 1 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
How to integrate data to drive sales
Inspired by a recent Agnitio roundtable discussion with Allergan, Ariad Pharmaceuticals, Astellas and Ipsen Pharma.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
-
Scientific Director
-
Highly Competitive Salary &Benefits
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
-
SENIOR MEDICAL WRITER IN ONCOLOGY
-
Up to £60, 000.00 pension bonus
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 benefits
-
Scientific Team Lead
-
Competitive Salary
- Senior Account Director development role to Business Director, H...
-
Excellent package
- Director Healthcare PR Communications
-
Salary TBC
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
-
Account Director - Digital
-
Great salary and benefits
- Senior Account Manager / Account Director - Med Comms
-
Great salary and benefits
-
Senior Account Manager - Med Comms
-
Highly Competitive Salary &Benefits
- Account Manager, Healthcare Advertising
-
Salary TBC
-
Account Director
-
Negotiable
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
- Account Director – Global Healthcare PR
-
Salary TBC
-
Associate Medical Director
-
Salary TBC
Subscribe to our email news alerts
- Tackling a formidable foe
- Cancer care – the power of new technologies
- AcelRX’s potent opioid tablets set to win FDA backing for pain relief
- New leader at Medivir after setbacks
- Roche preps new Kadcyla filings after phase 3 trial win
- Porterhouse Medical Group boosts its scientific services team with two new appointments
PMHub
Say Communications
Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...
Latest intelligence
- Tackling a formidable foe
- Ali Frederic Ben-Amor tells how Merck is taking the fight to multiple sclerosis...
- Cancer care – the power of new technologies
- With patient numbers set to soar, how can we make a difference?...
- Redefining communications excellence
- How to be heard in today’s multichannel, multistakeholder, multimedia world...
Quick links
Infographics
